These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35446985)

  • 41. Hereditary thrombotic thrombocytopenic purpura and the hereditary TTP registry.
    Mansouri Taleghani M; von Krogh AS; Fujimura Y; George JN; Hrachovinová I; Knöbl PN; Quist-Paulsen P; Schneppenheim R; Lämmle B; Kremer Hovinga JA
    Hamostaseologie; 2013 May; 33(2):138-43. PubMed ID: 23715103
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel compound heterozygote mutations (H234Q/R1206X) of the ADAMTS13 gene in an adult patient with Upshaw-Schulman syndrome showing predominant episodes of repeated acute renal failure.
    Shibagaki Y; Matsumoto M; Kokame K; Ohba S; Miyata T; Fujimura Y; Fujita T
    Nephrol Dial Transplant; 2006 May; 21(5):1289-92. PubMed ID: 16449289
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transfusion of Platelets Loaded With Recombinant ADAMTS13 (A Disintegrin and Metalloprotease With Thrombospondin Type 1 Repeats-13) Is Efficacious for Inhibiting Arterial Thrombosis Associated With Thrombotic Thrombocytopenic Purpura.
    Abdelgawwad MS; Cao W; Zheng L; Kocher NK; Williams LA; Zheng XL
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2731-2743. PubMed ID: 30354235
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current concepts in thrombotic thrombocytopenic purpura.
    Tsai HM
    Annu Rev Med; 2006; 57():419-36. PubMed ID: 16409158
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic defects leading to hereditary thrombotic thrombocytopenic purpura.
    Kokame K; Miyata T
    Semin Hematol; 2004 Jan; 41(1):34-40. PubMed ID: 14727257
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel homozygous missense ADAMTS13 mutation Y658C in a patient with recurrent thrombotic thrombocytopenic purpura.
    Lee SH; Park JH; Park SK; Lee EH; Choi JI; Visentin GP; Park TS; Oh SH; Kim SR
    Ann Clin Lab Sci; 2011; 41(3):273-6. PubMed ID: 22075512
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Paradigm shift of childhood thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency.
    Yagi H; Matsumoto M; Fujimura Y
    Presse Med; 2012 Mar; 41(3 Pt 2):e137-55. PubMed ID: 22264931
    [TBL] [Abstract][Full Text] [Related]  

  • 48. von Willebrand factor antigen: a biomarker for severe pregnancy complications in women with hereditary thrombotic thrombocytopenic purpura?
    Davidesko S; Pikovsky O; Al-Athamen K; Hackmon R; Erez O; Miodownik S; Rabinovich A
    J Thromb Haemost; 2023 Jun; 21(6):1623-1629. PubMed ID: 36889591
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interactions of von Willebrand factor and ADAMTS13 in von Willebrand disease and thrombotic thrombocytopenic purpura.
    Budde U; Schneppenheim R
    Hamostaseologie; 2014; 34(3):215-25. PubMed ID: 25010251
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An enzyme immunoassay of ADAMTS13 distinguishes patients with thrombotic thrombocytopenic purpura from normal individuals and carriers of ADAMTS13 mutations.
    Zhou W; Tsai HM
    Thromb Haemost; 2004 Apr; 91(4):806-11. PubMed ID: 15045144
    [TBL] [Abstract][Full Text] [Related]  

  • 51. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
    N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An ADAMTS13 mutation that causes hereditary thrombotic thrombocytopenic purpura: a case report and literature review.
    Li P; Jiang J; Xi Q; Yang Z
    BMC Med Genomics; 2021 Oct; 14(1):252. PubMed ID: 34702267
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Two newborn-onset patients of Upshaw-Schulman syndrome with distinct subsequent clinical courses.
    Tanabe S; Yagi H; Kimura T; Isonishi A; Kato S; Yoshida Y; Hayakawa M; Matsumoto M; Ohtaki S; Takahashi Y; Fujimura Y
    Int J Hematol; 2012 Dec; 96(6):789-97. PubMed ID: 23188471
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hereditary TTP/Upshaw-Schulman syndrome: the ductus arteriosus controls newborn survival.
    Fujimura Y
    Int J Hematol; 2024 May; 119(5):532-540. PubMed ID: 38536644
    [TBL] [Abstract][Full Text] [Related]  

  • 55. von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
    Moake JL
    Semin Hematol; 2004 Jan; 41(1):4-14. PubMed ID: 14727254
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Siblings with congenital thrombotic thrombocytopenic purpura].
    Funakoshi Y; Okada M; Matsumoto M; Kokame K; Moriuchi H
    Rinsho Ketsueki; 2017; 58(8):933-937. PubMed ID: 28883277
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thrombotic Thrombocytopenic Purpura: Beyond Empiricism and Plasma Exchange.
    Tsai HM
    Am J Med; 2019 Sep; 132(9):1032-1037. PubMed ID: 30928346
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dissociation between the level of von Willebrand factor-cleaving protease activity and disease in a patient with congenital thrombotic thrombocytopenic purpura.
    Snider CE; Moore JC; Warkentin TE; Finch CN; Hayward CP; Kelton JG
    Am J Hematol; 2004 Dec; 77(4):387-90. PubMed ID: 15551280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Keeping von Willebrand Factor under Control: Alternatives for ADAMTS13.
    Tersteeg C; Fijnheer R; Pasterkamp G; de Groot PG; Vanhoorelbeke K; de Maat S; Maas C
    Semin Thromb Hemost; 2016 Feb; 42(1):9-17. PubMed ID: 26595154
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Upshaw-Schulman Syndrome with a Novel Deletion in Exon 17 of ADAMTS 13 Gene.
    John BM; Kumar S; Saxena A
    Indian J Pediatr; 2022 Apr; 89(4):402-403. PubMed ID: 35066806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.